BofA Finance LLC has recently announced the pricing of its contingent income auto-callable yield notes, totaling $1,618,000. This offering is significant as it is fully guaranteed by Bank of America Corporation, a major player in the national commercial banking sector.
The notes are linked to the performance of the VanEck Gold Miners ETF and the iShares Silver Trust, which reflects BofA Finance's strategy to diversify its product offerings. Investors can expect a contingent coupon rate of 10.75% per annum, contingent upon the performance of the underlying assets.
Background
BofA Finance LLC operates under the SIC code 6021, which classifies it as part of the National Commercial Banks sector. The company is a subsidiary of Bank of America Corporation, which is headquartered in Charlotte, North Carolina. The recent filing history indicates multiple 424B2 forms filed on October 29, 2026, highlighting an active engagement in capital markets.
What the Filing Says
The filing details that the notes priced on October 27, 2026, and are set to issue on October 30, 2026. The document states, "Payments on the Notes will depend on the individual performance of the VanEck Gold Miners ETF and the iShares Silver Trust." This indicates a structured product that ties returns to market performance, which is typical in the current financial landscape.
Impact
This offering may attract a variety of investors looking for exposure to precious metals through structured products. The contingent nature of the coupon payments could appeal to those with a bullish outlook on gold and silver markets. Additionally, as BofA Finance is backed by Bank of America Corporation, the credit risk remains relatively low, which may enhance investor confidence.
What's Next
The filing does not specify what happens next, but investors will likely keep an eye on the performance of the underlying ETFs as the maturity date approaches.
Read Next
Workers United Files to Sell $8.4 Million in Amalgamated Stock
Carvana Co. files to sell 10 million shares of stock
Platford Giles Richard to Sell 55,617 Takeda Shares
Takeda's Teresa Bitetti to Sell 46,609 Shares Amid Tax Obligations
Kiniksa Pharmaceuticals reports significant stock sale by officer
Moat Ross to Sell Over 103,000 Shares of Kiniksa Pharmaceuticals










